North Atlantic Smaller Companies Investment Trust plc
Half-Yearly Report for the six months ended 31 July 2018
Registered in England and Wales number 1091347
objective of the company and financial highlights
The objective of the Company is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.
|
31 July 2018 (unaudited) |
31 January 2018 (audited) |
% Change |
|
|
|
|
Net asset value ("NAV") per 5p Ordinary Share*: |
|
|
|
Basic |
3,787p |
3,462p |
9.4 |
Diluted |
3,782p |
3,458p |
9.4 |
Basic adjusted# |
3,843p |
3,529p |
8.9 |
Diluted adjusted# |
3,838p |
3,525p |
8.9 |
Mid-market price of the 5p Ordinary Shares |
3,050p |
2,870p |
6.3 |
Discount to diluted net asset value |
19.4% |
17.0% |
|
Discount to diluted adjusted net asset value |
20.5% |
18.6% |
|
Standard & Poor's 500 Composite Index† |
2,145.9 |
1,989.9 |
7.8 |
Russell 2000 Index† |
1,273.1 |
1,109.9 |
14.7 |
US Dollar/Sterling exchange rate |
1.3118 |
1.42205 |
-7.8 |
Ongoing charges (annualised) |
1.1% |
1.0% |
|
* Includes current period.
# Adjusted to reflect Oryx International Growth Fund plc ("Oryx") under the equity method of accounting, which is how the Company previously accounted for its share of Oryx, prior to the adoption of IFRS 10. This is useful to the shareholder as it shows the NAV based on valuing Oryx at NAV. See note 5.
† Sterling adjusted.
chief executive's review
During the six month period to 31 July 2018 the fully diluted net asset value (with Oryx under the equity method of accounting) rose by +8.9% as compared to a rise in the sterling adjusted Standard & Poor's 500 Composite Index of +7.8%. The Standard and Poor's Index actually fell marginally but sterling relative to the dollar was notably weak falling from 1.42205 to 1.3118.
Income for the period amounted to a profit of £2,389,000 (31 July 2017: £2,592,000). Consistent with past policy, the Directors do not propose to pay a dividend (31 July 2017: nil). However, it is probable that a final dividend in respect of the current year will be paid as all brought forward losses against the revenue account will have been utilised.
quoted portfolio
UK - It is pleasing to note that the UK portfolio taken as a whole performed well. Oryx once again outperformed its benchmark. AssetCo plc rose 30% following good results as did Bioquell PLC and EKF Diagnostics Holdings plc. Polar Capital Holdings plc also performed notably well on better than expected results together with a significant increase in the dividend. MJ Gleeson Group plc, Goals Soccer Centres plc and Benchmark Holdings plc underperformed but did not have a material impact on the portfolio. Finally, 25% of the holding in Ten Entertainment Group plc was sold at a significant profit.
USA - The US portfolio outperformed the Index with Ambac Financial Group Inc. in particular performing notably well following partial resolution of some of the problems in Puerto Rico. The opportunity was taken to increase the holding in Inspired Entertainment Inc. and the stock has subsequently risen.
unquoted portfolio
A small investment was made in a US unquoted during the period and in early August a significant investment was made in Pelsis Limited, a global pest control business. However, at the same time, the holding in Curtis Gilmour Holding Company was sold at a very substantial profit from cost. The holding in GAJV Holdings Inc. is also for sale with the price being subject to arbitration.
AIFMD
The Company is working with the Financial Conduct Authority on finalising its application to be a Full-scope internally managed UK Alternative Investment Fund Manager ("UK AIFM"). The FCA has confirmed that NASCIT can no longer be a small registered UK AIFM that is internally managed but must be authorised as a result of its total assets passing €500 million.
outlook
The Company continues to be defensively positional with over £98.2 million in cash and Treasury bills. Equity markets are both volatile and in my opinion overvalued. Nevertheless I am reasonably confident that the Company will make further progress over the balance of the year provided there is no major melt down in equity markets.
C H B Mills
Chief Executive
13 September 2018
chief executive's review (continued)
top ten investments
as at 31 July 2018
Company |
|
Fair value £'000 |
% of net assets |
US Treasury Bills |
US Treasury Stock |
87,089 |
15.9 |
Oryx International Growth Fund Limited* |
UK Listed |
59,940 |
11.0 |
Polar Capital Holdings plc |
UK Quoted on AIM |
45,500 |
8.3 |
Ten Entertainment Group plc |
UK Listed |
38,700 |
7.1 |
Gleeson MJ Group plc |
UK Listed |
38,314 |
7.0 |
EKF Diagnostics Holdings plc |
UK Quoted on AIM |
33,026 |
6.0 |
Bioquell PLC |
UK Listed |
19,950 |
3.7 |
Harwood Private Equity Fund IV LP |
UK Unquoted |
16,129 |
3.0 |
Trident Private Equity Fund III LLP |
UK Unquoted |
15,808 |
2.9 |
Sherwood Holdings Limited |
UK Unquoted |
15,165 |
2.8 |
|
|
369,621 |
67.7 |
* Traded price under IFRS 10, incorporated in Guernsey.
All investments are valued at fair value.
interim management report
investment objective
The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation to its shareholders through investing in a portfolio of smaller companies which are principally based in countries bordering the North Atlantic Ocean.
material events
The Board do not consider that there were any material events during the period ended 31 July 2018.
material transactions
There were no material transactions during the period.
risk profile
The principal risks and uncertainties for the remaining six months of the year continue to be as described in the Annual Report for the year ended 31 January 2018 on pages 19 and 20 and pages 69 to 78. The principal risks arising from the Company's financial instruments are market price risk, including currency risk, interest rate risk and other price risk, liquidity risk and credit risk. The Directors review and agree policies with the Manager, Harwood Capital LLP, for managing these risks. The policies have remained substantially unchanged in the six months since the year end.
The Company does not have any significant exposure to credit risk arising from any one individual party. Credit risk is spread across a number of counterparties, each having an immaterial effect on the Company's cash flows, should a default happen. The Company assesses the credit worthiness of its debtors from time to time to ensure that they are neither past due or impaired.
To support its investment in unquoted companies, the Company may periodically agree to guarantee all or part of the borrowings of investee companies. Provision is made for any costs that may be incurred when the Directors consider it likely that the guarantee will crystallise.
The Company's exposure to market price risk comprises mainly movements in the value of the Company's investments. It should be noted that the prices of options tend to be more volatile than the prices of the underlying securities. The Manager assesses the exposure to market risk when making each investment decision and monitors the overall level of market risk on the whole of the investment portfolio on an ongoing basis.
The functional and presentational currency of the Company is Sterling, and therefore, the Company's principal exposure to foreign currency risk comprises investments priced in other currencies, principally US Dollars.
The Company invests in equities and other investments that are realisable.
related party transactions
These are listed in note 10 to the half yearly condensed financial statements.
By Order of the Board
Peregrine Moncreiffe
Chairman
13 September 2018
responsibility statement
The Directors confirm to the best of their knowledge that:
· The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard ("IAS") 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and profit of the Company; and
· The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and
· The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Company during the period and any changes therein.
The half yearly financial report was approved by the Board on 13 September 2018 and the above responsibility statement was signed on its behalf by:
Peregrine Moncreiffe
Chairman
13 September 2018
condensed statement of comprehensive income
|
Six months ended 31 July 2018 (unaudited) |
Six months ended 31 July 2017 (unaudited) |
Year ended 31 January 2018 (audited) |
||||||
|
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Revenue £'000 |
Capital £'000 |
Total £'000 |
Income |
5,273 |
- |
5,273 |
4,999 |
- |
4,999 |
10,115 |
- |
10,115 |
Net gains on investments at fair value |
- |
44,404 |
44,404 |
- |
28,724 |
28,724 |
- |
69,197 |
69,197 |
Currency exchange gains/(losses) |
- |
129 |
129 |
- |
(395) |
(395) |
- |
(769) |
(769) |
|
|
|
|
|
|
|
|
|
|
total income |
5,273 |
44,533 |
49,806 |
4,999 |
28,329 |
33,328 |
10,115 |
68,428 |
78,543 |
|
|
|
|
|
|
|
|
|
|
Expenses |
|
|
|
|
|
|
|
|
|
Investment management fee (note 10) |
(2,546) |
- |
(2,546) |
(2,190) |
(759) |
(2,949) |
(4,380) |
(2,749) |
(7,129) |
Other expenses |
(338) |
- |
(338) |
(213) |
- |
(213) |
(586) |
- |
(586) |
|
|
|
|
|
|
|
|
|
|
return before taxation |
2,389 |
44,533 |
46,922 |
2,596 |
27,570 |
30,166 |
5,149 |
65,679 |
70,828 |
|
|
|
|
|
|
|
|
|
|
Taxation |
- |
- |
- |
(4) |
- |
(4) |
(11) |
- |
(11) |
|
|
|
|
|
|
|
|
|
|
return for the period |
2,389 |
44,533 |
46,922 |
2,592 |
27,570 |
30,162 |
5,138 |
65,679 |
70,817 |
|
|
|
|
|
|
|
|
|
|
earnings per ordinary share (note 4) |
|
|
|
|
|
|
|
|
|
Basic |
|
|
325.3p |
|
|
209.1p |
|
|
490.9p |
Diluted |
|
|
324.9p |
|
|
209.1p |
|
|
490.8p |
The total column of the statement is the Statement of Comprehensive Income of the Company prepared in accordance with International Financial Reporting Standards ("IFRS"). The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice ("SORP") issued by the Association of Investment Companies ("AIC").
All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.
condensed statement of changes in equity
|
Share capital £'000 |
Share options reserve £'000 |
Share premium account £'000 |
Capital reserve £'000 |
Capital redemption reserve £'000 |
Revenue reserve £'000 |
Total £'000 |
six months ended 31 July 2018 (unaudited) |
|
|
|
|
|
|
|
31 January 2018 |
721 |
55 |
1,301 |
498,123 |
149 |
(926) |
499,423 |
Total comprehensive income for the period |
- |
- |
- |
44,533 |
- |
2,389 |
46,922 |
|
|
|
|
|
|
|
|
31 July 2018 |
721 |
55 |
1,301 |
542,656 |
149 |
1,463 |
546,345 |
|
|
|
|
|
|
|
|
six months ended 31 July 2017 (unaudited) |
|
|
|
|
|
|
|
31 January 2017 |
721 |
55 |
1,301 |
432,444 |
149 |
(6,064) |
428,606 |
Total comprehensive income for the period |
- |
- |
- |
27,570 |
- |
2,592 |
30,162 |
|
|
|
|
|
|
|
|
31 July 2017 |
721 |
55 |
1,301 |
460,014 |
149 |
(3,472) |
458,768 |
|
|
|
|
|
|
|
|
year ended 31 January 2018 (audited) |
|
|
|
|
|
|
|
31 January 2017 |
721 |
55 |
1,301 |
432,444 |
149 |
(6,064) |
428,606 |
Total comprehensive income for the year |
- |
- |
- |
65,679 |
- |
5,138 |
70,817 |
|
|
|
|
|
|
|
|
31 January 2018 |
721 |
55 |
1,301 |
498,123 |
149 |
(926) |
499,423 |
condensed balance sheet
|
As at 31 July 2018 (unaudited) £'000 |
As at 31 July 2017 (unaudited) £'000 |
As at 31 January 2018 (audited) £'000 |
non current assets |
|
|
|
Investments at fair value through profit or loss |
526,415 |
440,394 |
488,912 |
|
|
|
|
|
526,415 |
440,394 |
488,912 |
current assets |
|
|
|
Trade and other receivables |
11,279 |
3,808 |
3,943 |
Cash and cash equivalents |
11,066 |
15,815 |
10,653 |
|
|
|
|
|
22,345 |
19,623 |
14,596 |
|
|
|
|
total assets |
548,760 |
460,017 |
503,508 |
|
|
|
|
current liabilities |
|
|
|
Trade and other payables |
(2,415) |
(1,249) |
(4,085) |
|
|
|
|
total liabilities |
(2,415) |
(1,249) |
(4,085) |
|
|
|
|
total assets less current liabilities |
546,345 |
458,768 |
499,423 |
|
|
|
|
net assets |
546,345 |
458,768 |
499,423 |
|
|
|
|
represented by: |
|
|
|
Share capital |
721 |
721 |
721 |
Share options reserve |
55 |
55 |
55 |
Share premium account |
1,301 |
1,301 |
1,301 |
Capital reserve |
542,656 |
460,014 |
498,123 |
Capital redemption reserve |
149 |
149 |
149 |
Revenue reserve |
1,463 |
(3,472) |
(926) |
|
|
|
|
total equity attributable to equity holders of the company |
546,345 |
458,768 |
499,423 |
|
|
|
|
net asset value per ordinary share (note 5): |
|
|
|
Basic |
3,787p |
3,180p |
3,462p |
Diluted |
3,782p |
3,177p |
3,458p |
condensed cash flow statement
|
Six months ended 31 July 2018 (unaudited) £'000 |
Six months ended 31 July 2017 (unaudited) £'000 |
Year ended 31 January 2018 (audited) £'000 |
cash flows from operating activities |
|
|
|
Investment income received |
4,036 |
2,902 |
7,023 |
Deposit interest received |
5 |
- |
5 |
Other income |
- |
192 |
192 |
Investment Manager's fees and performance fees paid |
(3,654) |
(2,208) |
(4,398) |
Other cash payments |
(847) |
(363) |
(653) |
|
|
|
|
cash (expended)/generated from operations (note 7) |
(460) |
523 |
2,169 |
Taxation paid |
- |
(4) |
(11) |
|
|
|
|
net cash (outflow)/inflow from operating activities |
(460) |
519 |
(2,158) |
|
|
|
|
cash flows from investing activities |
|
|
|
Purchases of investments |
(195,357) |
(244,178) |
(431,754) |
Sales of investments |
196,188 |
247,782 |
428,896 |
|
|
|
|
net cash inflow/(outflow) from investing activities |
831 |
3,604 |
(2,858) |
|
|
|
|
increase/(decrease) in cash and cash equivalents for the period |
371 |
4,123 |
(700) |
cash and cash equivalents at the start of the period |
10,653 |
11,829 |
11,829 |
Revaluation of foreign currency balances |
42 |
(137) |
(476) |
|
|
|
|
cash and cash equivalents at the end of the period |
11,066 |
15,815 |
10,653 |
notes
1. a) general information
North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a Company incorporated and domiciled in Great Britain and registered in England and Wales.
The Company operates as an investment trust company within the meaning of Section 833 of the Companies Act 2006 and has made a successful application under Regulation 5 of the Investment Trust (Approved Company) (Tax) Regulations 2011 for investment trust status to apply to all accounting periods starting on or after 1 February 2013. The Company is managed in such a way to ensure that it continues to meet the eligibility conditions contained in Section 1158 of the Corporation Tax Act 2010 and the ongoing requirements outlined in Chapter 3 of Part 2 of the regulations.
b) basis of preparation
The condensed interim financial statements for the six months ended 31 July 2018 have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all financial information required for full annual financial statements and have been prepared using the accounting policies adopted in the audited financial statements for the year ended 31 January 2018. Those financial statements were prepared in accordance with IFRS and with the SORP for Investment Companies and Venture Capital Trusts issued by the AIC in November 2014 and updated in February 2018 with consequential amendments, except to any extent where it conflicts with IFRS.
The condensed interim financial information includes the financial statements of the Company, for the six months ended 31 July 2018.
c) measurement basis
These financial statements are presented in Sterling rounded to the nearest thousand.
d) significant accounting policies
The accounting policies applied are consistent with those of the Annual Financial Report for the year ended 31 January 2018. Since the year end no new standards have been adopted.
e) segmental reporting
The Directors are of the opinion that the Company is engaged in a single segment of business, being investment business. The Company invests in smaller companies principally based in countries bordering the North Atlantic Ocean.
f) going concern
The Company has adequate financial resources and no significant investment commitments and as a consequence, the Directors believe that the Company is well placed to manage its business risks successfully. After making appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate available financial resources to continue in operational existence for the foreseeable future and accordingly have concluded that it is appropriate to continue to adopt the going concern basis in preparing this half yearly financial report.
2. investment management and performance fees
A Performance Fee is only payable if the investment portfolio, including Oryx at the adjusted price, outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds, and is allocated 100% to capital.
In accordance with the SORP for investment trust companies, an amount would be included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2018.
At that date, a Performance Fee, inclusive of VAT, of £nil has been accrued for in the accounts (31 July 2017: £759,000; 31 January 2018: £2,749,000).
notes (continued)
3. taxation
The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.
During the half year to 31 July 2018, the Company recognised a total charge of £nil (half year to 31 July 2017: £4,000, year ended 31 January 2018: £11,000), representing irrecoverable withholding tax paid on overseas investment income.
4. earnings per ordinary share
|
Revenue |
Capital |
Total |
||||||
|
Net return £'000 |
Ordinary Shares |
Per Share pence |
Net Return £'000 |
Ordinary Shares |
Per Share pence |
Net Return £'000 |
Ordinary Shares |
Per Share pence |
six months ended 31 July 2018 (unaudited) |
|
|
|
|
|
|
|
|
|
Basic return per share |
2,389 |
14,425,620 |
16.6 |
44,533 |
14,425,620 |
308.7 |
46,922 |
14,425,620 |
325.3 |
Share options* |
- |
14,885 |
|
- |
14,885 |
|
- |
14,885 |
|
|
|
|
|
|
|
|
|
|
|
Diluted return per share |
2,389 |
14,440,505 |
16.5 |
44,533 |
14,440,505 |
308.4 |
46,922 |
14,440,505 |
324.9 |
|
|
|
|
|
|
|
|
|
|
six months ended 31 July 2017 (unaudited) |
|
|
|
|
|
|
|
|
|
Basic return per share |
2,592 |
14,425,620 |
18.0 |
27,570 |
14,425,620 |
191.1 |
30,162 |
14,425,620 |
209.1 |
Share options* |
- |
2,846 |
|
- |
2,846 |
|
- |
2,846 |
|
|
|
|
|
|
|
|
|
|
|
Diluted return per share |
2,592 |
14,428,466 |
18.0 |
27,570 |
14,428,466 |
191.1 |
30,162 |
14,428,466 |
209.1 |
|
|
|
|
|
|
|
|
|
|
year ended 31 January 2018 (audited) |
|
|
|
|
|
|
|
|
|
Basic return per share |
5,138 |
14,425,620 |
35.6 |
65,679 |
14,425,620 |
455.3 |
70,817 |
14,425,620 |
490.9 |
Share options* |
- |
3,324 |
|
- |
3,324 |
|
- |
3,324 |
|
|
|
|
|
|
|
|
|
|
|
Diluted return per share |
5,138 |
14,428,944 |
35.6 |
65,679 |
14,428,944 |
455.2 |
70,817 |
14,428,944 |
490.8 |
Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.
* Excess of total number of potential shares on Option Conversion over the number that could be issued at the average market price, as calculated in accordance with IAS 33: Earnings per share.
5. net asset value per ordinary share
The basic net asset value per Ordinary Share is based on net assets of £546,345,000 (31 July 2017: £458,768,000; 31 January 2018: £499,423,000) and on 14,425,620 Ordinary Shares (31 July 2017: 14,425,620; 31 January 2018: 14,425,620) being the number of Ordinary Shares in issue at the period end.
The diluted net asset value per Ordinary Share is calculated on the assumption that all 30,000 (31 July 2017: 30,000; 31 January 2018: 30,000) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 14,455,620 issued Ordinary Shares (31 July 2017: 14,455,620; 31 January 2018: 14,455,620).
During the period, there was no change to the Ordinary Shares in issue.
notes (continued)
5. net asset value per ordinary share (continued)
adjustment for Oryx
The Company has also reported an adjusted net asset value per share using equity accounting, in accordance with its previous method of valuing its investment in Oryx. The Company has chosen to report this net asset value per share to show the difference derived if equity accounting were to be used. Equity accounting permits the use of net asset value pricing for listed assets which in the case of Oryx is higher than its fair value.
The values of Oryx, as at each period end, are as follows:
|
31 July 2018 |
31 July 2017 |
31 January 2018 |
|
(unaudited) |
(unaudited) |
(audited) |
|
£'000 |
£'000 |
£'000 |
Oryx at Fair value (traded price) using IFRS 10 |
59,940 |
50,632 |
55,663 |
Oryx value using Equity Accounting |
67,968 |
60,830 |
65,368 |
Increase in net assets using Equity Accounting |
8,028 |
10,198 |
9,705 |
|
31 July 2018 |
31 July 2017 |
31 January 2018 |
|
(unaudited) |
(unaudited) |
(audited) |
Net asset value per Share |
|
|
|
- Basic |
3,787p |
3,180p |
3,462p |
- Diluted |
3,782p |
3,177p |
3,458p |
|
|
|
|
Net asset value per Share adjusted |
|
|
|
- Basic |
3,843p |
3,251p |
3,529p |
- Diluted |
3,838p |
3,247p |
3,525p |
6. share based remuneration
As at 31 July 2018 and as at 13 September 2018, there were a total of 30,000 options in issue with an estimated fair value of £0.4m (31 July 2017: 30,000; 31 January 2018: 30,000). 10,000 options are under the 2011 options scheme and 20,000 options are under the 2012 option scheme.
7. reconciliation of total return before taxation to cash (expended)/generated from operations
|
Six months ended 31 July 2018 (unaudited) £'000 |
Six months ended 31 July 2017 (unaudited) £'000 |
Year ended 31 January 2018 (audited) £'000 |
Total return before taxation |
46,922 |
30,166 |
70,828 |
Gains on investments |
(44,533) |
(28,329) |
(68,428) |
Interest reinvested |
- |
(870) |
(2,450) |
Net return from Subsidiary |
(7) |
(89) |
(82) |
Increase in debtors and accrued income |
(805) |
(1,247) |
(804) |
(Decrease)/increase in creditors and accruals |
(2,037) |
892 |
3,105 |
|
|
|
|
Cash (expended)/generated from operations |
(460) |
523 |
2,169 |
notes (continued)
8. investments
financial assets at fair value through profit or loss
The Company adopted the amendment to IFRS 13, effective 1 January 2009. This requires the Company to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy consists of the following three levels:
· Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.
An active market is a market in which transactions for the asset or liability occur with sufficient frequency and volume on an ongoing basis such that quoted prices reflect prices at which an orderly transaction would take place between market participants at the measurement date. Quoted prices provided by external pricing services, brokers and vendors are included in Level 1, if they reflect actual and regularly occurring market transactions on an arms length basis.
· Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).
· Level 3 - Inputs for the asset or liability that are not based on observable market data (unobservable inputs).
The Company's main unobservable inputs are earnings multiples, recent transactions and net asset basis. The market value would be sensitive to movements in these unobservable inputs. Movements in these inputs, individually or in aggregate could have a significant effect on the market value. The effect of such a change or a reasonable possible alternative would be difficult to quantify as such data is not available.
The level in the fair value hierarchy within which the fair value measurement is categorised in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgement, considering factors specific to the asset or liability.
The determination of what constitutes 'observable' requires significant judgement by the Company. The Company considers observable data from investments actively traded in organised financial markets, fair value is generally determined by reference to Stock Exchange quoted market bid prices at the close of business on the Balance Sheet date, without adjustment for transaction costs necessary to realise the asset.
The table below sets out fair value measurements of financial assets in accordance with the IFRS 13 fair value hierarchy system:
six months ended 31 July 2018 (unaudited)
|
Total £'000 |
Level 1 £'000 |
Level 2 £'000 |
Level 3 £'000 |
Equity investments |
397,117 |
334,188 |
- |
62,929 |
Fixed interest investments |
129,298 |
87,089 |
- |
42,209 |
|
|
|
|
|
Total |
526,415 |
421,277 |
- |
105,138 |
notes (continued)
8. investments (continued)
six months ended 31 July 2017 (unaudited)
|
Total £'000 |
Level 1 £'000 |
Level 2 £'000 |
Level 3 £'000 |
Equity investments |
340,746 |
291,445 |
- |
49,301 |
Fixed interest investments |
109,846 |
65,276 |
- |
44,570 |
|
|
|
|
|
Total |
450,592 |
356,721 |
- |
93,871 |
year ended 31 January 2018 (audited)
|
Total £'000 |
Level 1 £'000 |
Level 2 £'000 |
Level 3 £'000 |
Equity investments |
360,468 |
297,897 |
- |
62,571 |
Fixed interest investments |
128,444 |
95,612 |
- |
32,832 |
|
|
|
|
|
Total |
488,912 |
393,509 |
- |
95,403 |
level 3 financial assets at fair value through profit or loss
A reconciliation of fair value measurements in Level 3 is set out below:
at 31 July 2018
|
Total £'000 |
Equity investments £'000 |
Fixed interest investments £'000 |
|
|
|
|
Opening balance at 31 January 2018 |
95,403 |
62,571 |
32,832 |
|
|
|
|
Purchases |
5,833 |
1,526 |
4,307 |
Sales |
(202) |
(202) |
- |
|
|
|
|
Transfers between fixed interest and equity |
- |
(3,584) |
3,584 |
|
|
|
|
Total gains included in gains on investments in the statement of comprehensive income: |
|
|
|
- on assets sold |
202 |
202 |
- |
- on assets held at the end of the period |
3,902 |
2,416 |
1,486 |
|
|
|
|
Closing balance |
105,138 |
62,929 |
42,209 |
notes (continued)
8. investments (continued)
unquoted at directors' estimate of fair value
Unquoted investments are valued in accordance with the International Private Equity and Venture Capital Valuation ("IPEV") Guidelines. Their valuation incorporates all factors that market participants would consider in setting a price. The primary valuation techniques employed to value the unquoted investments are earnings multiples, recent transactions and the net asset basis. Valuations in local currency are translated into Sterling at the exchange rate ruling on the Balance Sheet date.
Included within the Statement of Comprehensive Income as at 31 July 2018, is a gain of £2,416,000 relative to the movement in the fair value of the unquoted investments valued using IPEV valuation techniques.
the valuation techniques applied are based on the following assumptions:
Unquoted investments are usually valued by reference to the valuation multiples of similar listed companies or from transactions of similar businesses. Where appropriate discounts are then applied to those comparable multiples to reflect differences in size and liquidity. These enterprise values are then adjusted for net debt to arrive at an equity valuation. Where companies are in compliance with the loan note terms these loans are generally held at par plus accrued interest (where applicable) unless the enterprise value suggests that the debt cannot be recovered.
9. principal risk profile
The principal risks which the Company faces include exposure to:
(i) market price risk, including currency risk, interest rate risk and other price risk;
(ii) liquidity risk; and
(iii) credit risk.
Further details of the Company's management of these risks and exposure to them is set out in Note 14 of the Company's Annual Report for the year ended 31 January 2018, as issued on 11 May 2018. There have been no changes to the management of or exposure to these risks since that date.
notes (continued)
10. related party transactions
There have been no changes to the related party arrangements or transactions as reported in the Statutory Annual Financial Report for the year ended 31 January 2018.
The Manager, Harwood Capital LLP, is regarded as a related party of the Company. The amounts payable to the Manager and Growth Financial Services Limited in respect of investment management for the six months to 31 July 2018 are as follows:
|
Six months ended 31 July 2018 (unaudited) £'000 |
Six months ended 31 July 2017 (unaudited) £'000 |
Year ended 31 January 2018 (audited) £'000 |
Annual fee |
2,546 |
2,190 |
4,380 |
Performance fee |
- |
745 |
2,560 |
Irrecoverable VAT thereon |
- |
14 |
189 |
|
|
|
|
|
2,546 |
2,949 |
7,129 |
Shareholders should also note any payments made under share based remuneration as disclosed in note 6 to these financial statements.
11. financial information
The financial information contained in this half yearly report does not constitute full Statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the periods ended 31 July 2018 and 31 July 2017 is not a financial year and has not been audited. The information for the financial year ended 31 January 2018 has been extracted from the latest published Financial Statements, which have been delivered to the Registrar of Companies. The Report of the Auditors on those Financial Statements contained no qualification or statement under Section 498 of the Companies Act 2006.
shareholder information
financial calendar
Announcement of results and annual report May
Annual General Meeting June
Half Yearly figures announced September
Half Yearly Report posted September
share price
The Company's mid-market share price is quoted daily in the Financial Times appearing under "Investment Companies".
It also appears on:
SEAQ Ordinary Shares: NAS
Trustnet: www.trustnet.com
net asset value
The latest net asset value of the Company can be found on the Harwood Capital LLP website: www.harwoodcapital.co.uk
share dealing
Investors wishing to purchase more Ordinary Shares or dispose of all or part of their holding may do so through a stockbroker. Many banks also offer this service.
The Company's registrars are Link Asset Services. In the event of any queries regarding your holding of shares, please contact the registrars on: 0871 664 0300, or by email on enquiries@linkgroup.co.uk
Changes of name or address must be notified to the registrars in writing at:
Link Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent BR3 4TU
shareholder information (continued)
Directors
Peregrine Moncreiffe (Chairman)
Christopher Mills (Chief Executive)
Lord Howard of Rising
G Walter Loewenbaum
Sir Charles Wake
Manager
Harwood Capital LLP
(Authorised and regulated by the Financial Conduct Authority)
6 Stratton Street
Mayfair
London W1J 8LD
Telephone: 020 7640 3200
Financial Adviser and Stockbroker
Winterflood Investment Trusts
The Atrium Building
Cannon Bridge
25 Dowgate Hill
London EC4R 2GA
Registered Office
6 Stratton Street
Mayfair
London W1J 8LD
Telephone: 020 7640 3200
Registrars
Link Asset Services
The Registry
34 Beckenham Road
Beckenham
Kent BR3 4TU
Auditors
KPMG LLP
15 Canada Square
London E14 5GL
Company Secretary
Derringtons Limited
Hyde Park House
5 Manfred Road
London SW15 2RS